News

2017

Confo Therapeutics is awarded € 2.6 million in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology

1 February 2017

Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system

31 January 2017

• 1
• ...
• 4
• 5
• 6